Two of three commonly prescribed non-vitamin K oral anticoagulants (NOACs)—dabigatran and apixaban—have similar rates of major bleeding compared with aspirin, a large systematic review and ...

People who have had a stroke called an intracerebral hemorrhage who take cholesterol-lowering drugs called statins may have a lower risk of having another stroke, especially ischemic stroke, compared ...

If the novel factor XI inhibitor abelacimab reaches the market for patients with atrial fibrillation (AF) who require anticoagulation, it may not be necessary to interrupt treatment ahead of invasive ...

Please provide your email address to receive an email when new articles are posted on . Early use of SSRI/SNRIs was not associated with risk of bleeding in patients. However, there was increased risk ...

Modern blood-thinning drugs (known as NOACs) reduce the risk of serious bleeding by up to 45 percent compared to the traditional drug warfarin in the treatment of blood clots in the legs and lungs, ...

Two scores widely used to determine whether patients are at high risk for bleeding after coronary stenting disagreed in 22% of patients, and one score underestimated the risk, warned investigators ...

Please provide your email address to receive an email when new articles are posted on . Up to 15% of older adults may routinely use aspirin for primary prevention. Many continue use despite knowing ...

There is a risk for some, a new study found, of dangerous bleeding from aspirin. The study out of Britain shows adults ages 75 and older who regularly take aspirin to help prevent heart attacks and ...

Novel agent abelacimab has potential to be a safer anticoagulant, according to the randomized AZALEA-TIMI 71 trial. The trial had been stopped early because of a surprisingly large reduction in bleeds ...